Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)

Trial Profile

PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)

Status: Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 15 Feb 2024

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Abiraterone acetate (Primary) ; Prednisone
  • Indications Adenocarcinoma; Prostate cancer
  • Focus Biomarker; Pharmacogenomic; Therapeutic Use
  • Acronyms PROMOTE
  • Most Recent Events

    • 08 Feb 2024 Planned End Date changed from 30 Dec 2023 to 30 Jun 2024.
    • 18 Feb 2023 Results (Between June 2013 and August 2015) assessing the prognostic value of 20 previously identified genes in patients metastatic castrate resistant prostate cancer, presented at the 2023 Genitourinary Cancers Symposium.
    • 13 Feb 2023 Planned End Date changed from 30 Dec 2022 to 30 Dec 2023.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top